![]() |
CYTK | Cytokinetics Inc |
Pharmaceutical Preparations |
Book value per $ invested | $ -0.03 |
Leverage | 109.66% |
Market Cap | $ 4.8B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -586.3m |
Margin | -845.77% |
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.